Laronde

Biotechnology, Medical, Therapeutics

Founded in 1/1/17

Cambridge, Massachusetts, United States

http://www.laronde.bio

For Profit

About Laronde

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Company Metrics

Employees: 1-10
Monthly Visits: 5241
Tech Stack: None active products

Financial Information

Estimated Revenue:
Total Funding: 490000000 USD
Last Funding: 440000000 USD (Series B)
Funding Status: Early Stage Venture

Technology Stack

Laronde actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Medical, Therapeutics

Headquarters: Cambridge, Massachusetts, United States

Employees